Resources

This report provides data and information on the current and projected global autodisable (AD) syringe market. It includes a PATH forecast of AD syringe demand from 2025 through 2028, which estimates a need for nearly 2 billion AD syringes in 2025 and relatively small fluctuations in global demand through 2028. Additionally, the report includes information about current market events (such as recent outbreaks), innovations (such as microarray patches), and key stakeholder interests that may impact the AD syringe market in the near future.

Improving maternal and child health is a foundational investment in long-term health and prosperity. It shapes life outcomes from birth through adulthood through safer pregnancy and deliveries, proper nutrition, and protection from deadly childhood diseases. These interventions are not only lifesaving; they are among the most cost-effective investments a government can make.As the US government seeks to redesign its approach to foreign aid, PATH’s Center for Advocacy and Policy has published a white paper identifying five key recommendations to ensure future investments can continue saving the lives of moms and kids around the world while aligning with American interests and values.

Cold Chain Temperature Data Job Aid: Supporting Cold Chain Maintenance Through the Use of Temperature Data provides temperature examples with brief instructions for health care workers, technicians, and other immunization or facility staff to use temperature data to help diagnose issues with the Cold Chain Equipment (CCE) by using FridgeTag and/or Remote Temperature Monitoring Devices and more accurately respond with more proactive optimized maintenance actions.Produced by PATH, JSI, Village Reach, and New Horizons.

The Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact (AMPLI-PPHI) aims to dramatically reduce maternal mortality and morbidity from postpartum hemorrhage—the leading cause of maternal death worldwide.AMPLI-PPHI consortium brings together Jhpiego, PATH, and the International Federation of Gynecology and Obstetrics (FIGO) to support Ministries of Health and ensure sustainable access to quality-assured drugs.

The integrated post-validation/verification surveillance (PVS) toolkits for neglected tropical diseases (NTDs) were developed as a part of the Bill & Melinda Gates Foundation-funded NTD Surveillance Planning Toolkit project (2022 to 2025). The project aimed to develop and pilot a toolkit for assessing the capacity for integrated disease surveillance and response in low- and middle-income countries to enhance capacity to detect signals and respond to potential recrudescence of NTDs that have been eliminated.The three resources on this page summarize findings and experiences in project countries Bangladesh, Nigeria, and Senegal.